Your shopping cart is currently empty

TP receptor antagonist-1 (compound 7m) serves as an antagonist for the thromboxane A2 receptor (TP receptor), exhibiting IC50 values of 9.46 μM for TPa and 8.49 μM for TPb. It is utilized in the study of cardiovascular diseases [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | TP receptor antagonist-1 (compound 7m) serves as an antagonist for the thromboxane A2 receptor (TP receptor), exhibiting IC50 values of 9.46 μM for TPa and 8.49 μM for TPb. It is utilized in the study of cardiovascular diseases [1]. |
| Targets&IC50 | Thromboxane A2 receptor β (TPb):8.49 μM, Thromboxane A2 receptor α (TPa):9.46 μM |
| In vitro | TP receptor antagonist-1 (compound 7m) demonstrates inhibitory effects in ex vivo human platelet aggregation assays at concentrations ranging from 10^-5 to 10^-7 M over a period of 3 minutes [1]. |
| Molecular Weight | 393.84 |
| Formula | C17H16ClN3O4S |
| Cas No. | 1448452-21-8 |
| Smiles | O(C1=C(S(NC(NC(C)C)=O)(=O)=O)C=C(C#N)C=C1)C2=CC=C(Cl)C=C2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.